ASP Isotopes Inc (ASPI)

NASD · Basic Materials · Specialty Chemicals · USA

ASP Isotopes Inc is a micro cap company (market value under $300 million) in the Specialty Chemicals industry.

ASP Isotopes Inc develops isotope enrichment technologies for nuclear medicine, semiconductors, and nuclear energy. The company operates enrichment facilities in South Africa producing enriched Carbon-14, Silicon-28, and Ytterbium-176 for pharmaceutical, semiconductor, and radiotherapy applications. It also owns Renergen, a natural gas explorer and producer of liquid helium and LNG in South Africa.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the ASP Isotopes Inc stock.

Our verdict on ASPI

Undervalued: intrinsic value $1.96 per share, market price $1.37, margin of safety 30.0% (as of 2026-11-17).

A 0.5x revenue multiple, discounted for its losses, values the shares at $1.96; the price of $1.37 is 30% below that value.

ETFs with the most weight in ASPI

17 more funds hold it; the full list is part of the paid plan.

More on ASPI

Browse

Peers in Specialty Chemicals

All 62 Specialty Chemicals stocks

Cheaper than ASPI in Specialty Chemicals

Is ASPI undervalued or overvalued?

ASPI is undervalued (as of the 2026-11-17 close). A 0.5x revenue multiple, discounted for its losses, values the shares at $1.96; the price of $1.37 is 30% below that value.

What is the intrinsic value of ASPI?

$1.96 per share (as of the 2026-11-17 close), against a market price of $1.37. That is a margin of safety of 30.0%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.